Design and Rationale of the Sevoflurane for Sedation in Acute Respiratory Distress Syndrome (SESAR) Randomized Controlled Trial

Design and Rationale of the Sevoflurane for Sedation in Acute Respiratory Distress Syndrome (SESAR) Randomized Controlled Trial

Preclinical studies have shown that volatile anesthetics may have beneficial effects on injured lungs, and pilot clinical data support improved arterial oxygenation, attenuated inflammation, and decreased lung epithelial injury in patients with acute respiratory distress syndrome (ARDS) receiving in...

Full description

Bibliographic Details
Main Authors: Raiko Blondonnet, Laure-Anne Simand, Perine Vidal, Lucile Borao, Nathalie Bourguignon, Dominique Morand, Lise Bernard, Laurence Roszyk, Jules Audard, Thomas Godet, Antoine Monsel, Marc Garnier, Christophe Quesnel, Jean-Etienne Bazin, Vincent Sapin, Julie A. Bastarache, Lorraine B. Ware, Christopher G. Hughes, Pratik P. Pandharipande, E. Wesley Ely, Emmanuel Futier, Bruno Pereira, Jean-Michel Constantin, Matthieu Jabaudon, on behalf of the SESAR Collaborative Group
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Journal of Clinical Medicine
Subjects:
acute respiratory distress syndrome
sevoflurane
inhaled sedation
clinical trial
Online Access:https://www.mdpi.com/2077-0383/11/10/2796

Internet

https://www.mdpi.com/2077-0383/11/10/2796

Similar Items